PEREGRINE CAPITAL MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$7,365,416
-18.8%
146,663
+2.1%
0.22%
-10.9%
Q2 2023$9,074,825
+26.4%
143,589
-10.0%
0.25%
+19.3%
Q1 2023$7,180,584
+127713.9%
159,604
+24.5%
0.21%
+17.6%
Q4 2022$5,618
-99.9%
128,242
+14.2%
0.18%
-26.7%
Q3 2022$7,399,000
+10.4%
112,288
-15.3%
0.24%
+18.8%
Q2 2022$6,699,000
-17.3%
132,621
+4.5%
0.20%
+5.2%
Q1 2022$8,104,000
-38.8%
126,868
+2.6%
0.19%
-27.5%
Q4 2021$13,246,000
+7.2%
123,669
+2.9%
0.26%
+3.5%
Q3 2021$12,355,000
-12.0%
120,169
-24.7%
0.26%
+1.6%
Q2 2021$14,037,000
-4.5%
159,583
+5.6%
0.25%
-7.4%
Q1 2021$14,693,000
-23.9%
151,112
-12.2%
0.27%
-25.9%
Q4 2020$19,312,000
+10.9%
172,198
-8.3%
0.37%
-20.6%
Q3 2020$17,414,000
+31.2%
187,849
+10.4%
0.46%
+22.5%
Q2 2020$13,268,000
+14.3%
170,107
-14.3%
0.38%
-9.4%
Q1 2020$11,606,000198,4670.42%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders